Researchers found substantial overlap in autonomic symptoms, orthostatic tachycardia, and functional impairment between long COVID and POTS.
|Articles|January 17, 2022
Daily OTC Pearl: Senna Plus
Author(s)Saro Arakelians, PharmD
Senna Plus should cause a bowel movement within 6 to 12 hours among individuals who experience occasional constipation.
Advertisement
OTC/Lifestyle Pearl of the Day: Senna Plus
Indication: Senna Plus is a combination medicine used to treat occasional
Insight:
- Directions: Take Senna Plus with a full glass of water.
- Do not take Senna Plus for more than 7 days in a row unless directed by a physician.
- Storage: Store at room temperature away from moisture and heat.
- It may be best to take this medicine at night or at bedtime. Senna Plus should cause a bowel movement within 6 to 12 hours.
- Because Senna Plus is used when needed, there may not be a dosing schedule.
- Adverse effects may include rectal bleeding, stomachache, gas, bloating, diarrhea and nausea
Sources:
Advertisement
Related to this article
A review of 69 studies finds influenza vaccines continue to reduce hospitalization and death, with no new safety concerns.
Isatuximab plus Iberdomide maintenance helps MRD-positive myeloma patients turn MRD-negative after transplant, with manageable safety.
Insulin efsitora alfa-gobe (Onswik; Eli Lilly and Company) is designed to deliver steady basal insulin levels over a full 7-day duration.
Vallerie McLaughlin, MD, explains why the ERS update strongly recommends sotatercept for patients with pulmonary arterial hypertension (PAH) who don't reach low-risk status on initial therapy.
Imaging data from the CONTENTed study suggest the type 2 inflammation that drives severe asthma may affect more than the airways.
Renal benefit appeared only in patients with albuminuria in a 75,455-person BMJ analysis, whereas sulfonylureas signaled faster decline without it.
Authors of a pharmacist-directed transitions-of-care study discuss what drives pneumococcal vaccine hesitancy and how pharmacists can build systematic vaccine screening into inpatient workflows.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
2
After 180 Years, Multiple Myeloma Gets a Definition of Cure
3
Influenza Vaccines Continue to Reduce Severe Disease and Death Across High-Risk Groups, Evidence Review Finds
4
Psilocybin-Assisted Therapy for AUD: Emerging Evidence, Clinical and Cost Implications, and Treatment Gaps
5